ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,649,000 | -54.0% | 681,045 | -52.2% | 0.07% | -52.7% |
| Q1 2016 | $18,819,000 | -40.8% | 1,424,595 | -31.1% | 0.15% | -43.0% |
| Q4 2015 | $31,807,000 | +28.1% | 2,068,078 | +3.3% | 0.26% | +25.8% |
| Q3 2015 | $24,829,000 | -10.1% | 2,002,315 | -0.8% | 0.21% | +5.6% |
| Q2 2015 | $27,607,000 | +17.1% | 2,018,064 | +2.4% | 0.20% | +16.5% |
| Q1 2015 | $23,576,000 | -49.5% | 1,971,244 | -46.1% | 0.17% | -50.6% |
| Q4 2014 | $46,716,000 | +16.3% | 3,658,293 | +22.1% | 0.34% | +6.5% |
| Q3 2014 | $40,178,000 | -61.9% | 2,994,977 | -54.4% | 0.32% | -58.4% |
| Q2 2014 | $105,444,000 | +77.4% | 6,569,725 | +99.3% | 0.78% | +80.5% |
| Q1 2014 | $59,428,000 | +279.8% | 3,296,045 | +225.6% | 0.43% | +270.7% |
| Q4 2013 | $15,649,000 | +15.9% | 1,012,248 | +11.5% | 0.12% | +11.5% |
| Q3 2013 | $13,498,000 | +25.1% | 907,746 | +8.9% | 0.10% | +15.6% |
| Q2 2013 | $10,790,000 | – | 833,830 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |